Back to 
RHUMBLINE ADVISERS
RHUMBLINE ADVISERS
RETAShowing 0 of 20 quarters
Position history for RHUMBLINE ADVISERS's holdings in REATA PHARMACEUTICALS INC-A
As of its Q2 2023 13F, RhumbLine Advisers held 48,033 shares of RETA (Reata Pharmaceuticals), worth $4.9M. RhumbLine Advisers' 13F filings listed RETA from Q4 2018 to Q2 2023, 19 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of RETA: WELLINGTON MANAGEMENT GROUP LLP